Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders

Targeted immune-modulating treatment with biological agents has revolutionized the management of immune-mediated inflammatory diseases, including rheumatologic conditions. The efficacy and tolerability of biological agents, from the initial tumour necrosis factor (TNF)-α inhibitors to the new anti-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcovich, Simone, De Simone, Clara, Genovese, Giovanni, Berti, Emilio, Cugno, Massimo, Marzano, Angelo Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443901/
https://www.ncbi.nlm.nih.gov/pubmed/30971924
http://dx.doi.org/10.3389/fphar.2019.00282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443901/
https://www.ncbi.nlm.nih.gov/pubmed/30971924
http://dx.doi.org/10.3389/fphar.2019.00282

Ejemplares similares